It encompasses tumor-infiltrating lymphocytes (TILs) as well as their subtype and activation state, programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1)-positive immune cells, macrophages, and myeloid-derived suppressor cells. This evidence concerns the gene PDCD1 and neoplasm.